Publicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (6)

2024

  1. Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review

    Cancers, Vol. 16, Núm. 1

  2. Molecular Profile of Subungual Melanoma: A MelaNostrum Consortium Study of 68 Cases Reporting BRAF, NRAS, KIT, and TERT Promoter Status

    Dermatology, Vol. 240, Núm. 1, pp. 164-169

2022

  1. ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma

    Molecular Oncology, Vol. 16, Núm. 11, pp. 2235-2259

  2. M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors

    British Journal of Cancer

2020

  1. T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma

    Journal of Investigative Dermatology, Vol. 140, Núm. 6, pp. 1253-1265

2018

  1. T-type calcium channels drive migration/invasion in BRAFV600E melanoma cells through Snail1

    Pigment Cell and Melanoma Research, Vol. 31, Núm. 4, pp. 484-495